1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Medical Affiars Reputation: Multiple Sclerosis (EU5)

Medical Affiars Reputation: Multiple Sclerosis (EU5)

  • June 2016
  • ID: 4000243
  • Format: PDF
  • By Firstword Pharma

Summary

Table of Contents




MS medical affairs: oral therapies outperforming in Europe. How does your team measure up?

In Europe’s Multiple Sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy counterparts—earning the 3 highest scores for overall quality of interactions.

Find out which platform therapy’s team ranks highest, and where your team stands in Medical Affairs Reputations: MS.

The report compares teams for 10 major MS treatments head to head. You’ll learn how neurologists rate them for performance and satisfaction in 12 key areas that reveal how well they:

Provide relevant information
Respond to medical inquiries
Help enhance patient care
Support clinical trials and grant applications
And more.

So you can see where your team leads, where it lags behind, and what you can do to improve.





Answering Key Questions about Medical Affairs Teams for 10 Major MS Drugs

Aubagio (teriflunomide; Genzyme): Aubagio’s team needs improvement in three specific areas. Which ones, and how important are they to doctors?
Avonex (interferon beta-1a; Biogen): Is Avonex’s team better at providing competitive information or helping enhance patient access, education, and outcomes?
Betaferon (interferon beta-1b; Bayer): Betaferon’s team does a slightly better job than Rebif’s team of delivering three specific services. What are they?
Copaxone (glatiramer acetate; Teva): Which team is lagging farther behind in the two areas most important to doctors, Copaxone’s or Betaferon’s?
Gilenya (fingolimod; Novartis): Gilenya and Aubagio are just about tied for overall quality of interactions. Which team gets substantially higher satisfaction scores?
Lemtrada (alemtuzumab; Genzyme): Lemtrada’s team earns high satisfaction scores in more than half of the areas surveyed. Does that translate into a high overall quality rating?
Plegridy (peginterferon beta-1a; Biogen): Plegridy’s team is substantially more active than Betaferon’s. Has it earned a commensurate lead in overall quality score?
Rebif (interferon beta-1a; Merck Serono): Which team is more responsive, Rebif’s or Copaxone’s?
Tecfidera (dimethyl fumarate; Biogen): Which two rival teams’ overall quality scores are within one point of Tecfidera’s?
Tysabri (natalizumab; Biogen): Tysabri’s team needs improvement in two areas. What are they, and which one is more important to doctors?


Top Takeaways

Oral therapies lead the market: Ranked for overall quality of interactions, all of the top 3 teams represent oral therapies.
Interferons underperform: The top-ranked team for an interferon is more than three and a half points behind the lowest-ranked team for an oral therapy.
A key role in grant applications: Although providing clinical information is medical affairs teams’ top role, European doctors also rely on them to provide information about research grants.
Good performance, variable satisfaction: Most teams perform well in most areas—especially key areas. But satisfaction scores tend to be lower and vary more from team to team.
Clear roadmaps for improvement: Every team needs to improve in at least two of the twelve surveyed areas.
Clear communication preferences: EU5 doctors overwhelmingly prefer in-person interactions, but which type is best? Are they open to digital communications as well?
Do doctors want frequent interactions? Find out how many want to see medical affairs teams more than once per quarter, and how many say that’s too often.
More information, better attitude wanted: Doctors say teams can improve services by providing more information¬, improving their attitude, and being more organized.





An Expert-designed Competitive View of Your Medical Affairs Team

Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of 10 medical affairs teams—answering important questions like:/Paragraph>

What do doctors need?/Paragraph>

How, and how often are they using your medical affairs team?
What services do they consider most important?
How often should you contact them? What channels are best?

Does your medical affairs team deliver?/Paragraph>

How memorable are your team’s interactions with doctors?
How do doctors rank your team for performance and satisfaction in 12 key areas?
How does your team compare to the competition—in each area, and overall?

What needs improvement?/Paragraph>

Are you delivering the services that are most important to doctors?
Where do you need to improve?
How can your team enhance its services?




Based on Interviews with Practicing Neurologists

We surveyed 150 neurologists—30 from each EU5 country (France, Italy, Germany, Spain, UK)—chosen from the largest community of validated physicians in the world.

All respondents:

Have been practicing for between 3 and 35 years
See at least 5 patients with MS in a typical month
Devote at least 50% of their time to direct patient care
Have interacted with at least one listed product’s medical affairs team in the last 6 months.

We conducted the survey between May 2nd and 16th, 2016




Money Back Guarantee!
At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.












Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2020 Germany Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Test, Emerging technologies, Latest Instrumentation

2020 Germany Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Test, Emerging technologies, Latest Instrumentation

  • $ 3500
  • January 2020

2020 Germany Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Test, Emerging technologies, Latest Ins ...

2020 POC Lipid Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts--Physician Offices, ERs, Ambulatory Care Centers--Profiles of Leading Competitors

2020 POC Lipid Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts--Physician Offices, ERs, Ambulatory Care Centers--Profiles of Leading Competitors

  • $ 3500
  • January 2020

2020 POC Lipid Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts--Physician Offices, ERs, Ambulatory Care Centers--Profiles of Leading CompetitorsThis new 340-page report ...

Succeeding in the 2020 Global CMV Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Succeeding in the 2020 Global CMV Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 3500
  • February 2020

Succeeding in the 2020 Global CMV Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesThe ...


ref:plp2016

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on